Israel – Pfizer Real-World Epidemiological Evidence Collaboration Agreement

• Post author:GHIAA Editor
• Post published:May 6, 2021
• Post category:

Continue Reading Israel – Pfizer Real-World Epidemiological Evidence Collaboration Agreement

Regeneron – ATI Agreement for Large-Scale Manufacturing of Antibodies Directed to SARS-CoV-2

• Post author:GHIAA Admin
• Post published:April 16, 2021
• Post category:

Continue Reading Regeneron – ATI Agreement for Large-Scale Manufacturing of Antibodies Directed to SARS-CoV-2

Novavax–US Army Statement of Work for Rapid (WF10) Advanced Research & Development to Large Scale Manufacturing of NVX-CoV-2373 as a Vaccine for SARS-CoV-2 Coronavirus, under the Base Agreement between Novavax and Advanced Technology International

• Post author:GHIAA Admin
• Post published:March 23, 2021
• Post category:

Continue Reading Novavax–US Army Statement of Work for Rapid (WF10) Advanced Research & Development to Large Scale Manufacturing of NVX-CoV-2373 as a Vaccine for SARS-CoV-2 Coronavirus, under the Base Agreement between Novavax and Advanced Technology International

Advance Purchase Agreement for the Production, Purchase and Supply of a COVID-19 Vaccine in the European Union with AstraZeneca

• Post author:GHIAA Admin
• Post published:March 12, 2021
• Post category:

Continue Reading Advance Purchase Agreement for the Production, Purchase and Supply of a COVID-19 Vaccine in the European Union with AstraZeneca

Sanofi – DoD Agreement for Adjuvanted Recombinant COVID-19 Vaccine Development

• Post author:GHIAA Admin
• Post published:February 25, 2021
• Post category:

Continue Reading Sanofi – DoD Agreement for Adjuvanted Recombinant COVID-19 Vaccine Development

Advance Purchase Agreement for the Development, Production, Advance Purchase and Supply of a COVID-19 Vaccine for EU Member States with CureVac

• Post author:GHIAA Admin
• Post published:February 25, 2021
• Post category:

Continue Reading Advance Purchase Agreement for the Development, Production, Advance Purchase and Supply of a COVID-19 Vaccine for EU Member States with CureVac

Award Contract No. W911QY20C0100, by and between ModernaTX, Inc. and the Department of Defense

• Post author:GHIAA Admin
• Post published:January 19, 2021
• Post category:

Continue Reading Award Contract No. W911QY20C0100, by and between ModernaTX, Inc. and the Department of Defense

Moderna – BARDA Agreement (Contract No.75A50122C00034 for Development of an mRNA Vaccine for Sars-Cov-2)

• Post author:GHIAA Admin
• Post published:January 19, 2021
• Post category:

Continue Reading Moderna – BARDA Agreement (Contract No.75A50122C00034 for Development of an mRNA Vaccine for Sars-Cov-2)

NIH Model License Agreement for Use by Non-Profit

• Post author:GHIAA Editor
• Post published:May 21, 2020
• Post category:

Continue Reading NIH Model License Agreement for Use by Non-Profit